Tuesday, June 11, 2013 6:06:45 PM
New High Surf Alert $PLPL Company Profile
PLPL - Plandai Biotechnology, Inc.
Company Overview
Website - http://www.plandaibiotech.com
Company Highlights:
1. On November 17, 2011, the Company, through its wholly-owned subsidiary, Plandaí Biotechnologies, Inc., consummated a share exchange with Global Energy Solutions, Inc. (“GES”), an Irish corporation.
2. Cash on Hand - $574,000.00
3. Last 9 Months Ending on 3/31/13 - PLPL Generated $331,000.00 In Revenue Growth.
4. Plandaí Biotechnology is the culmination of over ten years of research in the field of plant extracts. Its principle holdings consist of land, farms and infrastructure, totaling more than 7500 acres in the province of Mpumalanga, South Africa.
5.Plandaí Biotechnology, Inc. and its subsidiaries, are encompassed in the following entities, which have been consolidated in the accompanying financial statements:
A. Dunn Roman Holdings—Africa, Ltd. - 82% owned by Plandaí Biotechnology, Inc.
B. Breakwood Trading 22 (Pty) Ltd. - 74% owned by Dunn Roman Holdings-Africa.
C. Green Gold Biotechnologies (Pty) Ltd. - 74% owned by Dunn Roman Holdings-Africa.
Plandaí Biotechnology is the culmination of over 10 years of research in the field of live plant extracts. Plandaí Biotechnology, Inc. intends to transform the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market.
Plandaí Biotechnology delivers highly bioavailable, phytonutrient rich extracts under the trademark, Phytofare™. These findings are supported by synthesized analogs, USDA manuscripts and academic findings.
Our headquarters are in Seattle, Washington in the United States, but we have a global presence with offices in London, England and Nelspruit in the province of Mpumalanga, South Africa. This enables us to react more efficiently to any market changes as well as to any customer requirements, worldwide.
Products
http://www.plandaibiotech.com/products.html
Current Projects
http://www.plandaibiotech.com/current-projects.html
Senteeko Estate
Plandaí Biotechnology, Inc., through its wholly owned subsidiaries, farms over 7500 acres of luscious land in the Mpumalanga province of South Africa.
It farms a whole fruit basket of produce which it uses in its creation of highly bioavailable extracts, ranging from citrus to avocado pears to most notably over 2000 acres of tea.
The tea plant, Camellia Sinensis, is an evergreen shrub or tree and can grow to heights of 30 feet, though for cultivation is pruned to heights of 2-5 feet.
Farming in South Africa is like no other country in the world and because of this we needed to make sure that we stacked the deck in our favor and employed only the best as every step of the product creation pathway is critical. With that in mind, our farming team has over 100 years of experience in managing farms in Southern Africa.
Research and Development
http://www.plandaibiotech.com/research-development.html
Plandai Biotechnology, Inc. is a fully reporting SEC company, publicly traded on the OTC Market under the symbol, “PLPL”, and within the OTC-QB market tier. As such, Business, Operational, and Financial information on Plandai Biotechnology, Inc. is fully transparent and available to publicly view.
Visit: http://www.otcmarkets.com/stock/PLPL/company-info to see complete details.
Plandai Biotechnology, Inc. is Active on the Nevada Secretary of State site:
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=6xjfEzplayjYH%252bbfyYH%252bMQ%253d%253d&nt7=0
A/S: 500 Million - per Nevada State
O/S: 110 Million - as of 5/10/13
(Please note the share structure posted is what we have gathered but can change on a daily basis. Contact the Company or Transfer Agent to get the most current information.)
Their latest 10-Q Quarterly Report:
Filed on 5/20/13 - For the period ending 3/31/13
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9306374
Incorporated In: Nevada in 2012
Transfer Agent:
Signature Stock Transfer, Inc.
2632 Coachlight Court
Plano, TX 75093
Phone: 972-612-4120
Email: SignatureStock@aol.com
Disclaimer
The following Press Releases have not been investigated by Wall Street Surfers, therefore we have no idea if the content of this news is based on Fact or Fiction. Although the links for the following press releases may be from a familiar and reputable company, you should NOT assume that a press wire hosted by a website you are familiar with is accurate just because it is on their site. Wall Street Surfers will not be held responsible for any news release including and not limited to misleading or non-factual content, or the accuracy of the identity of the given source of the press release.
Marketwired - (June 11 @ 9:05am ET)
Plandai's Products May Inhibit Prostate Cancer Growth
http://finance.yahoo.com/news/plandais-products-may-inhibit-prostate-130500017.html
Marketwired - (June 6)
Plandai Benefits From Industry's EGCG Alzheimer Studies
http://finance.yahoo.com/news/plandai-benefits-industrys-egcg-alzheimer-130100275.html
Marketwired - (June 6)
Plandai Biotechnology, Inc. Is Taking On the Malaria Parasite and Winning
http://finance.yahoo.com/news/plandai-biotechnology-inc-taking-malaria-123000777.html
Marketwired - (June 4)
Plandai Products to Assist in Weight Management
http://finance.yahoo.com/news/plandai-products-assist-weight-management-130100583.html
Marketwired - (May 31)
Plandai Has Huge Opportunity With Its Malaria Treatment
http://finance.yahoo.com/news/plandai-huge-opportunity-malaria-treatment-130100428.html
Contact Information
Plandai Biotechnology, Inc.
2226 Eastlake Ave. E - #156
Seattle, WA 98102
Phone: 425-466-0212
Email:info@plandaibiotech.com
This Alert Brought to you by Wall Street Surfers
Newsletter Sign Up - http://www.wallstreetsurfers.com
PLPL - Plandai Biotechnology, Inc.
Company Overview
Website - http://www.plandaibiotech.com
Company Highlights:
1. On November 17, 2011, the Company, through its wholly-owned subsidiary, Plandaí Biotechnologies, Inc., consummated a share exchange with Global Energy Solutions, Inc. (“GES”), an Irish corporation.
2. Cash on Hand - $574,000.00
3. Last 9 Months Ending on 3/31/13 - PLPL Generated $331,000.00 In Revenue Growth.
4. Plandaí Biotechnology is the culmination of over ten years of research in the field of plant extracts. Its principle holdings consist of land, farms and infrastructure, totaling more than 7500 acres in the province of Mpumalanga, South Africa.
5.Plandaí Biotechnology, Inc. and its subsidiaries, are encompassed in the following entities, which have been consolidated in the accompanying financial statements:
A. Dunn Roman Holdings—Africa, Ltd. - 82% owned by Plandaí Biotechnology, Inc.
B. Breakwood Trading 22 (Pty) Ltd. - 74% owned by Dunn Roman Holdings-Africa.
C. Green Gold Biotechnologies (Pty) Ltd. - 74% owned by Dunn Roman Holdings-Africa.
Plandaí Biotechnology is the culmination of over 10 years of research in the field of live plant extracts. Plandaí Biotechnology, Inc. intends to transform the world of nutraceuticals by making available extracts from live plant material that deliver the highest levels of bioavailability currently in the market.
Plandaí Biotechnology delivers highly bioavailable, phytonutrient rich extracts under the trademark, Phytofare™. These findings are supported by synthesized analogs, USDA manuscripts and academic findings.
Our headquarters are in Seattle, Washington in the United States, but we have a global presence with offices in London, England and Nelspruit in the province of Mpumalanga, South Africa. This enables us to react more efficiently to any market changes as well as to any customer requirements, worldwide.
Products
http://www.plandaibiotech.com/products.html
Current Projects
http://www.plandaibiotech.com/current-projects.html
Senteeko Estate
Plandaí Biotechnology, Inc., through its wholly owned subsidiaries, farms over 7500 acres of luscious land in the Mpumalanga province of South Africa.
It farms a whole fruit basket of produce which it uses in its creation of highly bioavailable extracts, ranging from citrus to avocado pears to most notably over 2000 acres of tea.
The tea plant, Camellia Sinensis, is an evergreen shrub or tree and can grow to heights of 30 feet, though for cultivation is pruned to heights of 2-5 feet.
Farming in South Africa is like no other country in the world and because of this we needed to make sure that we stacked the deck in our favor and employed only the best as every step of the product creation pathway is critical. With that in mind, our farming team has over 100 years of experience in managing farms in Southern Africa.
Research and Development
http://www.plandaibiotech.com/research-development.html
Plandai Biotechnology, Inc. is a fully reporting SEC company, publicly traded on the OTC Market under the symbol, “PLPL”, and within the OTC-QB market tier. As such, Business, Operational, and Financial information on Plandai Biotechnology, Inc. is fully transparent and available to publicly view.
Visit: http://www.otcmarkets.com/stock/PLPL/company-info to see complete details.
Plandai Biotechnology, Inc. is Active on the Nevada Secretary of State site:
http://nvsos.gov/sosentitysearch/CorpDetails.aspx?lx8nvq=6xjfEzplayjYH%252bbfyYH%252bMQ%253d%253d&nt7=0
A/S: 500 Million - per Nevada State
O/S: 110 Million - as of 5/10/13
(Please note the share structure posted is what we have gathered but can change on a daily basis. Contact the Company or Transfer Agent to get the most current information.)
Their latest 10-Q Quarterly Report:
Filed on 5/20/13 - For the period ending 3/31/13
http://www.otcmarkets.com/edgar/GetFilingHtml?FilingID=9306374
Incorporated In: Nevada in 2012
Transfer Agent:
Signature Stock Transfer, Inc.
2632 Coachlight Court
Plano, TX 75093
Phone: 972-612-4120
Email: SignatureStock@aol.com
Disclaimer
The following Press Releases have not been investigated by Wall Street Surfers, therefore we have no idea if the content of this news is based on Fact or Fiction. Although the links for the following press releases may be from a familiar and reputable company, you should NOT assume that a press wire hosted by a website you are familiar with is accurate just because it is on their site. Wall Street Surfers will not be held responsible for any news release including and not limited to misleading or non-factual content, or the accuracy of the identity of the given source of the press release.
Marketwired - (June 11 @ 9:05am ET)
Plandai's Products May Inhibit Prostate Cancer Growth
http://finance.yahoo.com/news/plandais-products-may-inhibit-prostate-130500017.html
Marketwired - (June 6)
Plandai Benefits From Industry's EGCG Alzheimer Studies
http://finance.yahoo.com/news/plandai-benefits-industrys-egcg-alzheimer-130100275.html
Marketwired - (June 6)
Plandai Biotechnology, Inc. Is Taking On the Malaria Parasite and Winning
http://finance.yahoo.com/news/plandai-biotechnology-inc-taking-malaria-123000777.html
Marketwired - (June 4)
Plandai Products to Assist in Weight Management
http://finance.yahoo.com/news/plandai-products-assist-weight-management-130100583.html
Marketwired - (May 31)
Plandai Has Huge Opportunity With Its Malaria Treatment
http://finance.yahoo.com/news/plandai-huge-opportunity-malaria-treatment-130100428.html
Contact Information
Plandai Biotechnology, Inc.
2226 Eastlake Ave. E - #156
Seattle, WA 98102
Phone: 425-466-0212
Email:info@plandaibiotech.com
This Alert Brought to you by Wall Street Surfers
Newsletter Sign Up - http://www.wallstreetsurfers.com
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.